UNICEF recently announced it had awarded a contract with a value of up to USD 170 million that will lead to 18 million doses of Mosquirix™ RTS,S/AS01 (RTS,S) being available over the next three years, potentially saving thousands of lives every year.
GSK's Mosquirix is a recombinant malaria vaccine that is the first and only malaria vaccine shown in pivotal long-term clinical trials to reduce malaria in children significantly.
Malaria Vaccine Supply Significantly Increases
Pandemic Tied to Worse Pregnancy-Related Complications, Maternal Death
However, no worsening observed in preexisting racial and ethnic disparities
Pediatric Populations Less Likely to Get Long COVID
Vaccination tied to lower risk for persistent COVID-19 symptoms at more than 12 weeks since infection
Surgical Procedure Volumes Dropped During COVID-19 Peak
During post-COVID-19-peak period, partial recovery was seen to 85.8 percent of pre-COVID-19-peak volumes, with variation across subspecialties
Patients Have Higher Health Care Use After COVID-19 Infection
Alopecia, bronchitis, pulmonary embolism or deep vein thrombosis, and dyspnea are the most common conditions tied to higher use
Biden Administration May Stop Buying COVID-19 Vaccines, Treatments by Fall
Tests, vaccines, and treatments would be provided through the regular health care system
CDC Director Says Agency Needs Major Overhaul
Walensky aims to prioritize public health needs, deemphasize publication of scientific papers about rare diseases
Will Millions of Monkeypox Vaccines be Needed?
The U.S. Department of Health and Human Services (HHS) announced yesterday that it is making up to 442,000 doses of the Jynneos® vaccine available under an accelerated Phase of the National Vaccine Strategy (NVS) to combat the current monkeypox virus (MPXV) outbreak in the USA.
In light of the recent U.S. FDA Emergency Use Authorization and revised dosing guidelines from the Centers for Disease Control and Prevention, HHS doubled the number of doses available as initially anticipated.
First Lady Jill Biden Has COVID-19
First Lady has received two vaccines plus two boosters, and so far, her symptoms are mild
COVID-19 Risk for Dialysis Patients Tied to Antibody Response to Vaccine
During omicron, risk for SARS-CoV-2 infection dependent on antibody response to COVID-19 vaccine regardless of number of doses